Previous close | 0.0500 |
Open | 0.1500 |
Bid | 0.0000 |
Ask | 4.2000 |
Strike | 610.00 |
Expiry date | 2024-05-10 |
Day's range | 0.0500 - 0.1500 |
Contract range | N/A |
Volume | |
Open interest | 16 |
First Quarter Results Show Revenue Decline but Strong Dupixent and Libtayo Sales Growth
It is hard to get excited after looking at Regeneron Pharmaceuticals' (NASDAQ:REGN) recent performance, when its stock...
Regeneron Pharmaceuticals earnings and sales missed first-quarter estimates early Thursday. Shares fell slightly.